Plasma fatty acid composition in French-Canadian children with non-alcoholic fatty liver disease: Effect of n-3 PUFA supplementation. (August 2015)
- Record Type:
- Journal Article
- Title:
- Plasma fatty acid composition in French-Canadian children with non-alcoholic fatty liver disease: Effect of n-3 PUFA supplementation. (August 2015)
- Main Title:
- Plasma fatty acid composition in French-Canadian children with non-alcoholic fatty liver disease: Effect of n-3 PUFA supplementation
- Authors:
- Spahis, S.
Alvarez, F.
Dubois, J.
Ahmed, N.
Peretti, N.
Levy, E. - Abstract:
- Abstract: Non-alcoholic fatty liver disease (NAFLD) represents one of the most common causes of liver disease worldwide. As the NAFLD pathogenesis is associated with diet and lifestyle, the aims of the present work are to assess fatty acid (FA) composition in NAFLD young French-Canadian, to determine whether treatment with n-3 FA improves the plasma FA profile, and to define the time on the effectiveness of n-3 FA supplementation. Baseline characteristics of the NAFLD subjects show increased, anthropometric and biochemical parameters. Their plasma FA composition is characterized by a percent increase in total n-6 FA and a high proportion of saturated and total monounsaturated FA, as well as a decrease in Δ5 and increase in Δ6 desaturases. In conclusion, our results document for the first time the composition of plasma FAs in NAFLD young French Canadian and the efficacy of 3-month supplementation to improve the proportion of n-3 FA in their plasma. Highlights: For the first time, a composition of plasma fatty acids characterizes the French-Canadian children with NAFLD. The n-3 fatty acid intake is safety for the young French Canadian NAFLD subjects and effective without physical activity or nutritional intervention. 3-month supplementations are sufficient to improve the composition of fatty acid in French-Canadian children with NAFLD.
- Is Part Of:
- Prostaglandins, leukotrienes, and essential fatty acids. Volume 99(2015:Aug.)
- Journal:
- Prostaglandins, leukotrienes, and essential fatty acids
- Issue:
- Volume 99(2015:Aug.)
- Issue Display:
- Volume 99 (2015)
- Year:
- 2015
- Volume:
- 99
- Issue Sort Value:
- 2015-0099-0000-0000
- Page Start:
- 25
- Page End:
- 34
- Publication Date:
- 2015-08
- Subjects:
- AA Arachidonic acid -- CVD Cardiovascular disease -- DHA Docosahexaenoic acid -- EPA Eicosapentaenoic acid -- FA Fatty acids -- HDL High-density lipoprotein -- LA Linoleic acid -- NAFLD Non-alcoholic fatty liver disease -- PUFA Polyunsaturated fatty acid -- SFA Saturated fatty acid -- TG Triglycerides
Fatty acids -- PUFA -- n-3 fatty acids -- Supplementation -- Obesity -- NAFLD
Lipids -- Periodicals
Unsaturated fatty acids -- Periodicals
Prostaglandins -- Periodicals
Leukotrienes -- Periodicals
Fatty Acids, Unsaturated -- Periodicals
Acides gras insaturés -- Périodiques
Prostaglandines -- Périodiques
Leucotriènes -- Périodiques
Lipides -- Périodiques
612.01577 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09523278 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09523278 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09523278 ↗
http://www.elsevier.com/journals ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1016/j.plefa.2015.04.010 ↗
- Languages:
- English
- ISSNs:
- 0952-3278
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6935.190900
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 6683.xml